Evidence map›Paper›PMID 36927157›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2023

EMBER multidimensional spectral microscopy enables quantitative determination of disease- and cell-specific amyloid strains.

Hyunjun Yang, Peng Yuan, Yibing Wu, Marie Shi, Christoffer D Caro, Atsushi Tengeiji, Shigeo Yamanoi, Masahiro Inoue, William F DeGrado, Carlo Condello

Full text read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. A functional amyloid scaffold shapes insect egg coats.bioRxiv : the preprint server for biology · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. A brain-derived tau oligomer polymorph is associated with cognitive resilience to Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  8. Review
  9. Article
  10. Binding adaptability of chemical ligands to polymorphic α-synuclein amyloid fibrils.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  11. Article
  12. Chemical science · 2024
    Article
  13. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Hyunjun YangInstitute for Neurodegenerative Diseases, University of California, San Francisco, CA 94143.ORCID 0000-0003-2524-2201
Peng YuanInstitute for Neurodegenerative Diseases, University of California, San Francisco, CA 94143.ORCID 0000-0003-4051-4447
Yibing WuDepartment of Pharmaceutical Chemistry, Cardiovascular Research Institute, University of California, San Francisco, CA 94158.
Marie ShiInstitute for Neurodegenerative Diseases, University of California, San Francisco, CA 94143.
Christoffer D CaroInstitute for Neurodegenerative Diseases, University of California, San Francisco, CA 94143.
Atsushi TengeijiDaiichi Sankyo Co. Limited, Tokyo 103-8426, Japan.
Shigeo YamanoiDaiichi Sankyo Co. Limited, Tokyo 103-8426, Japan.
Masahiro InoueDaiichi Sankyo Co. Limited, Tokyo 103-8426, Japan.
William F DeGradoInstitute for Neurodegenerative Diseases, University of California, San Francisco, CA 94143.ORCID 0000-0003-4745-263X
Carlo CondelloInstitute for Neurodegenerative Diseases, University of California, San Francisco, CA 94143.

Funding

TDP-43 Loss-of-Function: Biology to BiomarkersP01AG019724 · NIA · UNIVERSITY OF PENNSYLVANIA · PI Jennifer Merrilees · 2002 to 2026
$67.2M
VIRAL DEGENERATIVE DEMENTING DISEASE IN AGING (SUPP)P01AG002132 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SALI, ANDREJ · 1985 to 2024
$51.7M
THE ROLE OF ADVANCED CAA IN ALZHEIMER'S DEMENTIAP50AG005134 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI HYMAN, BRADLEY T. · 1985 to 2018
$42.1M
The Alzheimer's Disease Research Center at the University of California, IrvineP30AG066519 · NIA · UNIVERSITY OF CALIFORNIA-IRVINE · PI Mathew Mark Blurton-Jones · 2020 to 2026
$27.9M
PrPSc SPECIFIC INTERACTION WITH NOVEL PrP-Fc FUSION PROTEINSP50AG023501 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MILLER, BRUCE L · 2004 to 2018
$27.1M
Deciphering the relationship between structure, dynamics and function in helical bundle proteinsR35GM122603 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WILLIAM DEGRADO · 2017 to 2026
$7.1M
Relationships between conformational strains of tau and amyloid-beta, TREM2 and APOE variants, and phenotypic variations of Alzheimer's DiseaseRF1AG061874 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CONDELLO, CARLO L, DEGRADO, WILLIAM · 2018 to 2018
$2.0M
NIA NIH HHS P01 AG002132NIA NIH HHS P01 AG019724NIA NIH HHS P30 AG066519NIA NIH HHS P50 AG005134NIA NIH HHS P50 AG023501NIA NIH HHS RF1 AG061874NIGMS NIH HHS R35 GM122603
6 · The paper itself

Abstract

In neurodegenerative diseases, proteins fold into amyloid structures with distinct conformations (strains) that are characteristic of different diseases. However, there is a need to rapidly identify amyloid conformations in situ. Here, we use machine learning on the full information available in fluorescent excitation/emission spectra of amyloid-binding dyes to identify six distinct different conformational strains in vitro, as well as amyloid-β (Aβ) deposits in different transgenic mouse models. Our EMBER (excitation multiplexed bright emission recording) imaging method rapidly identifies conformational differences in Aβ and tau deposits from Down syndrome, sporadic and familial Alzheimer's disease human brain slices. EMBER has in situ identified distinct conformational strains of tau inclusions in astrocytes, oligodendrocytes, and neurons from Pick's disease. In future studies, EMBER should enable high-throughput measurements of the fidelity of strain transmission in cellular and animal neurodegenerative diseases models, time course of amyloid strain propagation, and identification of pathogenic versus benign strains.

Indexed as

Alzheimer DiseasePick Disease of the BrainAmyloidAmyloid beta-PeptidesAnimalsBrainHumansMiceMice, TransgenicMicroscopyPlaque, Amyloidtau ProteinsAmyloidAmyloid beta-Peptidestau Proteinsconformational strainfluorescent excitation/emissionmachine learningneurodegenerative diseasesproteins fold

Identifiers

PMID36927157
PMCPMC10041141

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read16
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.